Meningioma and schwannoma managementNeurofibromatosis and Schwannoma CasesHead and Neck Surgical OncologyHearing Loss and RehabilitationEar Surgery and Otitis Media
Publications
51
Citations
601
Est. group size
~2
Recurring co-author estimate
Active years
78
Publishing since 1949
Publication cadence
Publications per year over the last 10 years — averaging 2.8/year recently
Recent publications
- Hearing and Speech Perception are Associated with A/T/N Biomarkers of Alzheimer's Disease
Alzheimer s & Dementia · 2025
- Reduction of sporadic and neurofibromatosis type 2–associated vestibular schwannoma growth in vitro and in vivo after treatment with the c-Jun N-terminal kinase inhibitor AS602801
Journal of neurosurgery · 2022
- PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2)
Human Molecular Genetics · 2021
- EXTH-13. REDUCTION OF TUMOR BURDEN AND HEARING LOSS WITH A MULTIPLE RECEPTOR TYROSINE KINASE INHIBITOR BRIGATINIB IN A GENETICALLY ENGINEERED MOUSE MODEL OF NEUROFIBROMATOSIS TYPE 2
Neuro-Oncology · 2018
- An assessment of a conical horn waveguide to represent the human eardrum
Journal of Physics D Applied Physics · 2018
- Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2
PMC · 2017
- Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2
Oncotarget · 2017
Publishes in
- Otology & Neurotology×8
- PLoS ONE×2
- Human Molecular Genetics×2
- PMC×2
- Alzheimer s & Dementia×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile